Scandinavian Medical Solutions AS (SMSMED) - Net Assets
Based on the latest financial reports, Scandinavian Medical Solutions AS (SMSMED) has net assets worth Dkr82.67 Million DKK (≈ $12.93 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr205.86 Million ≈ $32.21 Million USD) and total liabilities (Dkr123.19 Million ≈ $19.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read SMSMED current and long-term liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr82.67 Million |
| % of Total Assets | 40.16% |
| Annual Growth Rate | 72.47% |
| 5-Year Change | 242.87% |
| 10-Year Change | N/A |
| Growth Volatility | 138.98 |
Scandinavian Medical Solutions AS - Net Assets Trend (2019–2025)
This chart illustrates how Scandinavian Medical Solutions AS's net assets have evolved over time, based on quarterly financial data. Also explore Scandinavian Medical Solutions AS asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Scandinavian Medical Solutions AS (2019–2025)
The table below shows the annual net assets of Scandinavian Medical Solutions AS from 2019 to 2025. For live valuation and market cap data, see Scandinavian Medical Solutions AS (SMSMED) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | Dkr82.67 Million ≈ $12.93 Million |
+0.22% |
| 2024-09-30 | Dkr82.48 Million ≈ $12.91 Million |
+10.79% |
| 2023-09-30 | Dkr74.45 Million ≈ $11.65 Million |
+19.72% |
| 2022-09-30 | Dkr62.19 Million ≈ $9.73 Million |
+157.93% |
| 2021-09-30 | Dkr24.11 Million ≈ $3.77 Million |
+394.01% |
| 2020-09-30 | Dkr4.88 Million ≈ $763.57K |
+55.49% |
| 2019-09-30 | Dkr3.14 Million ≈ $491.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Scandinavian Medical Solutions AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2586.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Dkr81.65 Million | 98.77% |
| Common Stock | Dkr1.11 Million | 1.34% |
| Other Comprehensive Income | Dkr-89.00K | -0.11% |
| Total Equity | Dkr82.67 Million | 100.00% |
Scandinavian Medical Solutions AS Competitors by Market Cap
The table below lists competitors of Scandinavian Medical Solutions AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Spring Art Holdings Bhd
KLSE:0216
|
$12.52 Million |
|
Spring Ventures Ltd
TA:SPRG
|
$12.53 Million |
|
Edinburgh Investment Trust
LSE:EDIN
|
$12.53 Million |
|
Turmalina Metals Corp
V:TBX
|
$12.53 Million |
|
Schweizer Electronic AG
F:SCE
|
$12.52 Million |
|
Smith Micro Software Inc
NASDAQ:SMSI
|
$12.51 Million |
|
Bayhorse Silver Inc
V:BHS
|
$12.51 Million |
|
Scidev Ltd
AU:SDV
|
$12.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Scandinavian Medical Solutions AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 82,483,000 to 82,665,000, a change of 182,000 (0.2%).
- Net income of 26,000 contributed positively to equity growth.
- New share issuances of 245,000 increased equity.
- Other comprehensive income decreased equity by 89,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr26.00K | +0.03% |
| Share Issuances | Dkr245.00K | +0.3% |
| Other Comprehensive Income | Dkr-89.00K | -0.11% |
| Total Change | Dkr- | 0.22% |
Book Value vs Market Value Analysis
This analysis compares Scandinavian Medical Solutions AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.97x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 25.09x to 0.97x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-09-30 | Dkr0.12 | Dkr2.89 | x |
| 2020-09-30 | Dkr0.18 | Dkr2.89 | x |
| 2021-09-30 | Dkr1.16 | Dkr2.89 | x |
| 2022-09-30 | Dkr2.33 | Dkr2.89 | x |
| 2023-09-30 | Dkr2.73 | Dkr2.89 | x |
| 2024-09-30 | Dkr3.00 | Dkr2.89 | x |
| 2025-09-30 | Dkr2.99 | Dkr2.89 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Scandinavian Medical Solutions AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.01%
- • Asset Turnover: 1.19x
- • Equity Multiplier: 2.49x
- Recent ROE (0.03%) is below the historical average (38.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 96.81% | 9.74% | 3.33x | 2.99x | Dkr2.72 Million |
| 2020 | 92.43% | 10.75% | 2.46x | 3.50x | Dkr4.02 Million |
| 2021 | 33.83% | 11.39% | 1.60x | 1.85x | Dkr5.75 Million |
| 2022 | 18.29% | 10.29% | 1.04x | 1.71x | Dkr5.15 Million |
| 2023 | 16.42% | 6.39% | 1.17x | 2.20x | Dkr4.78 Million |
| 2024 | 9.44% | 3.44% | 1.30x | 2.11x | Dkr-461.30K |
| 2025 | 0.03% | 0.01% | 1.19x | 2.49x | Dkr-8.24 Million |
Industry Comparison
This section compares Scandinavian Medical Solutions AS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,196,316,200
- Average return on equity (ROE) among peers: 21.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Scandinavian Medical Solutions AS (SMSMED) | Dkr82.67 Million | 96.81% | 1.49x | $12.52 Million |
| Ambu A/S (AMBU-B) | $294.12 Million | 8.84% | 0.89x | $2.44 Billion |
| ChemoMetec A/S (CHEMM) | $73.01 Million | 24.95% | 0.56x | $925.73 Million |
| Demant A/S (DEMANT) | $756.47 Million | 104.51% | 2.82x | $7.91 Billion |
| GN Store Nord (GN) | $4.85 Billion | 29.99% | 2.44x | $2.13 Billion |
| ViroGates A/S (VIRO) | $8.98 Million | -60.13% | 0.34x | $15.97 Million |
About Scandinavian Medical Solutions AS
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. The company offers equipment in the categories of Cath Lab, CT Machine, mammogram, PET/CT, Spect/CT, X-ray, ultrasound, MRI, Gamma/Spect, C-arm, mobile X-ray, R/F, mobile solutions, and others; as well as provides CT, MRI, Cath Lab, X-ray, mammography, ultrasound PET/CT, and C-arm parts. It also provides rental solut… Read more